MSLP Muscle Pharm Corp.

MusclePharm to Participate at the 34th Annual Roth Conference

MusclePharm to Participate at the 34th Annual Roth Conference

LAS VEGAS, March 02, 2022 (GLOBE NEWSWIRE) -- MusclePharm Corporation (“MusclePharm” or the “Company”) (OTCMKTS: MSLP), a global provider of leading sports nutrition and lifestyle branded nutritional supplements, today announced that Ryan Drexler, the Company’s Chief Executive Officer; Sabina Rizvi, the Company’s President and Chief Financial Officer; and T.J. Dillashaw, the Company’s Head of Marketing and Business Development, will be participating at the 34th Annual Roth Conference, to be held March 13-15, 2022 in Dana Point, CA.

The Company will be participating in one-on-one and small group meetings on Monday, March 14 and Tuesday, March 15, 2022. There will be no formal presentation.

About MusclePharm Corporation

MusclePharm® is an award-winning, worldwide leading sports nutrition and lifestyle Company offering branded nutritional supplements. Its portfolio of recognized properties includes the MusclePharm® Sport Series, Essentials Series, and recently-launched Natural Series, as well as FitMiss™–a product line designed specifically for female athletes. MusclePharm® products are available in more than 100 countries globally, with its Combat Protein product lineup being the Company’s most popular.

Contact:

John Mills, Managing Partner

ICR, Inc.

646-277-1254



EN
02/03/2022

Underlying

MSLPMuscle Pharm Corp.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Muscle Pharm Corp.

 PRESS RELEASE
Free
MSLP Muscle Pharm Co...

MusclePharm Announces Private Placement of $2.5 Million Senior Secured...

MusclePharm Announces Private Placement of $2.5 Million Senior Secured Notes LAS VEGAS, June 06, 2022 (GLOBE NEWSWIRE) -- MusclePharm Corporation (“MusclePharm” or the “Company”) (OTCPINK: MSLP), a global provider of leading sports nutrition and lifestyle branded nutritional supplements, today announced that it has entered into a definitive agreement with certain institutional and accredited investors pursuant to which the Company has increased its October 2021 offering to provide for the issuance and sale of an additional Senior Secured Notes and warrants (the “Offering”). The definitiv...

June 6, 2022 1 EN
 PRESS RELEASE
Free
MSLP Muscle Pharm Co...

MusclePharm to Present at the LD Micro Invitational XII Conference

MusclePharm to Present at the LD Micro Invitational XII Conference LAS VEGAS, May 24, 2022 (GLOBE NEWSWIRE) -- MusclePharm Corporation (“MusclePharm” or the “Company”) (OTCMKTS: MSLP), a global provider of leading sports nutrition and lifestyle branded nutritional supplements, today announced that Ryan Drexler, the Company’s Chief Executive Officer, and Sabina Rizvi, the Company’s President and Chief Financial Officer, will be presenting at the LD Micro Invitational XII Conference, to be held June 7-9, 2022 at Four Seasons Westlake Village. The MusclePharm investor presentation is schedul...

May 24, 2022 1 EN
 PRESS RELEASE
Free
MSLP Muscle Pharm Co...

MusclePharm Announces First Quarter 2022 Financial Results

MusclePharm Announces First Quarter 2022 Financial Results Company Revenue Increases 31% Sequentially to $13.1 Million in First Quarter of 2022 Second Consecutive Quarter of Margin Improvement Despite Industry-Wide Supply Challenges Company Triples MP Performance Energy Sales in First Quarter of 2022 from Fourth Quarter of 2021 to Over $1.1 Million; Delivers Energy Margins of 35% in First Quarter of 2022 LAS VEGAS, May 16, 2022 (GLOBE NEWSWIRE) -- MusclePharm Corporation (“MusclePharm” or the “Company”) (OTCMKTS: MSLP), a global provider of leading sports nutrition and lifestyle brande...

May 16, 2022 1 EN
 PRESS RELEASE
Free
MSLP Muscle Pharm Co...

MusclePharm to Announce First Quarter 2022 Financial Results on Monday...

MusclePharm to Announce First Quarter 2022 Financial Results on Monday, May 16, 2022 LAS VEGAS, May 10, 2022 (GLOBE NEWSWIRE) -- MusclePharm Corporation (“MusclePharm” or the “Company”) (OTCMKTS: MSLP), a global provider of leading sports nutrition and lifestyle branded nutritional supplements, announced today that the Company will report its financial results for the first quarter ended March 31, 2022, after the market closes on Monday, May 16, 2022. The Company will host a conference call to discuss its operating results on Monday, May 16, 2022, at 1:30 pm Pacific Time (4:30 pm Eastern...

May 10, 2022 1 EN
 PRESS RELEASE
Free
MSLP Muscle Pharm Co...

Correction: MusclePharm Announces Fourth Quarter and Fiscal Year 2021 ...

Correction: MusclePharm Announces Fourth Quarter and Fiscal Year 2021 Financial Results Company Delivers $10.0 Million of Net Revenue in Fourth Quarter 2021 and $50.0 Million of Net Revenue for Full Year 2021 Operating Expenses Decline $2.7 Million or 16% for Full Year 2021 Company Sells More Than 1.4 Million Cans of MP Performance Energy Since Launch; Delivers Fourth Quarter 2021 Energy Margins of 35% and Full Year 2021 Energy Margins of 45% LAS VEGAS, May 05, 2022 (GLOBE NEWSWIRE) -- MusclePharm Corporation is issuing this press release to correct its press release dated April 14, 20...

May 5, 2022 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch